{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:57:43Z","timestamp":1791755863622,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s40265-021-01544-8","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T09:03:20Z","timestamp":1625130200000},"page":"1193-1201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":179,"title":["Remimazolam: A Review in Procedural Sedation"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6519-7831","authenticated-orcid":false,"given":"Arnold","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Shirley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"issue":"1","key":"1544_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/EJA.0000000000000683","volume":"35","author":"J Hinkelbein","year":"2018","unstructured":"Hinkelbein J, Lamperti M, Akeson J, et al. European Society of Anaesthesiology and European Board of Anaesthesiology guidelines for procedural sedation and analgesia in adults. Eur J Anaesthesiol. 2018;35(1):6\u201324.","journal-title":"Eur J Anaesthesiol"},{"key":"1544_CR2","unstructured":"Benzoni T, Cascella M. Procedural sedation. StatPearls. Treasure Island (FL); 2020. https:\/\/www.ncbi.nlm.nih.gov\/. Accessed 21 May 2021."},{"issue":"3","key":"1544_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/ALN.0000000000002043","volume":"128","author":"American Society of Anesthesiologists","year":"2018","unstructured":"American Society of Anesthesiologists. Practice guidelines for moderate procedural sedation and analgesia 2018. Anesthesiology. 2018;128(3):437\u201379.","journal-title":"Anesthesiology"},{"issue":"10","key":"1544_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s40263-017-0463-7","volume":"31","author":"J Brohan","year":"2017","unstructured":"Brohan J, Goudra BG. The role of GABA receptor agonists in anesthesia and sedation. CNS Drugs. 2017;31(10):845\u201356.","journal-title":"CNS Drugs"},{"issue":"3","key":"1544_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.mayocpiqo.2017.10.002","volume":"1","author":"RA Helmers","year":"2017","unstructured":"Helmers RA, Dilling JA, Chaffee CR, et al. Overall cost comparison of gastrointestinal endoscopic procedures with endoscopist- or anesthesia-supported sedation by activity-based costing techniques. Mayo Clin Proc Innov Qual Outcomes. 2017;1(3):234\u201341.","journal-title":"Mayo Clin Proc Innov Qual Outcomes."},{"issue":"2","key":"1544_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1213\/ANE.0b013e31823acb95","volume":"115","author":"JR Sneyd","year":"2012","unstructured":"Sneyd JR. Remimazolam: new beginnings or just a me-too? Anesth Analg. 2012;115(2):217\u20139.","journal-title":"Anesth Analg"},{"issue":"2","key":"1544_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.gie.2017.07.018","volume":"87","author":"DS Early","year":"2018","unstructured":"Early DS, Lightdale JR, Vargo JJ, et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2018;87(2):327\u201337.","journal-title":"Gastrointest Endosc"},{"issue":"11","key":"1544_CR8","doi-asserted-by":"publisher","first-page":"1000690","DOI":"10.4172\/2155-6148.1000690","volume":"7","author":"J Colao","year":"2016","unstructured":"Colao J, Correa DR. Rapidly metabolized anesthetics: novel alternative agents for procedural sedation. J Anesth Clin Res. 2016;7(11):1000690.","journal-title":"J Anesth Clin Res."},{"issue":"4","key":"1544_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/17512433.2021.1901575","volume":"14","author":"W Chen","year":"2021","unstructured":"Chen W, Chen S, Huang Y. Induction and maintenance of procedural sedation in adults: focus on remimazolam injection. Expert Rev Clin Pharmacol. 2021;14(4):411\u201326.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1544_CR10","unstructured":"Acacia Pharma Inc. BYFAVO\u2122 (remimazolam): US prescribing information. 2021. https:\/\/www.accessdata.fda.gov. Accessed 21 May 2021."},{"key":"1544_CR11","unstructured":"European Medicines Agency. Byfavo (remimazolam): EU summary of product characteristics 2021. https:\/\/www.ema.europa.eu\/. Accessed 21 May 2021."},{"issue":"1","key":"1544_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","volume":"107","author":"GJ Kilpatrick","year":"2007","unstructured":"Kilpatrick GJ, McIntyre MS, Cox RF, et al. CNS 7056: a novel ultra-short-acting benzodiazepine. Anesthesiology. 2007;107(1):60\u20136.","journal-title":"Anesthesiology"},{"issue":"8","key":"1544_CR13","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1111\/bcp.14270","volume":"86","author":"RB Kleiman","year":"2020","unstructured":"Kleiman RB, Darpo B, Thorn M, et al. Potential strategy for assessing QT\/QTc interval for drugs that produce rapid changes in heart rate: electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarization. Br J Clin Pharmacol. 2020;86(8):1600\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"1544_CR14","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/jcph.1614","volume":"60","author":"F Schippers","year":"2020","unstructured":"Schippers F, Pesic M, Saunders R, et al. Randomized crossover trial to compare abuse liability of intravenous remimazolam versus intravenous midazolam and placebo in recreational central nervous system depressant users. J Clin Pharmacol. 2020;60(9):1189\u201397.","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"1544_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s40268-020-00317-0","volume":"20","author":"M Pesic","year":"2020","unstructured":"Pesic M, St\u00f6hr T, Ossig J, et al. Remimazolam has low oral bioavailability and no potential for misuse in drug-facilitated sexual assaults, with or without alcohol: results from two randomised clinical trials. Drugs R D. 2020;20(3):267\u201377.","journal-title":"Drugs R D."},{"issue":"1","key":"1544_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","volume":"155","author":"NJ Pastis","year":"2019","unstructured":"Pastis NJ, Yarmus LB, Schippers F, et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019;155(1):137\u201346.","journal-title":"Chest"},{"issue":"3","key":"1544_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","volume":"88","author":"DK Rex","year":"2018","unstructured":"Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88(3):427-37.e6.","journal-title":"Gastrointest Endosc"},{"key":"1544_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.dld.2020.10.039","volume":"53","author":"DK Rex","year":"2021","unstructured":"Rex DK, Bhandari R, Lorch DG, et al. Safety and efficacy of remimazolam in high risk colonoscopy: a randomized trial. Dig Liver Dis. 2021;53:94\u2013101.","journal-title":"Dig Liver Dis"},{"issue":"5","key":"1544_CR19","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.gie.2015.08.062","volume":"83","author":"DJ Pambianco","year":"2016","unstructured":"Pambianco DJ, Borkett KM, Riff DS, et al. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2016;83(5):984\u201392.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"1544_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1213\/ANE.0000000000000548","volume":"120","author":"KM Borkett","year":"2015","unstructured":"Borkett KM, Riff DS, Schwartz HI, et al. A phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy. Anesth Analg. 2015;120(4):771\u201380.","journal-title":"Anesth Analg"},{"key":"1544_CR21","unstructured":"US Food and Drug Administration. 212295Orig1s000 clinical review(s) 2020. https:\/\/www.accessdata.fda.gov. Accessed 21 May 2021."},{"key":"1544_CR22","unstructured":"Pastis N, Schippers F, Imre M, et al. Correlating depth of sedation with vital signs and adverse events in bronchoscopy [abstract no. D45]. In: AJRCCM 2020."},{"key":"1544_CR23","unstructured":"Fresenius Kabi. Midazolam injection, USP: US prescribing information. 2021. https:\/\/www.accessdata.fda.gov. Accessed 21 May 2021."},{"issue":"4","key":"1544_CR24","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/ACO.0000000000000877","volume":"33","author":"JR Sneyd","year":"2020","unstructured":"Sneyd JR, Rigby-Jones AE. Remimazolam for anaesthesia or sedation. Curr Opin Anaesthesiol. 2020;33(4):506\u201311.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"3","key":"1544_CR25","first-page":"111","volume":"62","author":"V Schekenbach","year":"2021","unstructured":"Schekenbach V, Hofmann P, Drexler B. Remimazolam: the future of TIVA? [German]. An\u00e4sth Intensivmed. 2021;62(3):111\u20137.","journal-title":"An\u00e4sth Intensivmed."},{"key":"1544_CR26","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s10620-020-06044-5","volume":"65","author":"B Goudra","year":"2020","unstructured":"Goudra B, Gouda G, Mohinder P. Recent developments in drugs for GI endoscopy sedation. Dig Dis Sci. 2020;65:2781\u20138.","journal-title":"Dig Dis Sci"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-021-01544-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-021-01544-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-021-01544-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T12:26:44Z","timestamp":1626352004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-021-01544-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1544"],"URL":"https:\/\/doi.org\/10.1007\/s40265-021-01544-8","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"21 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The preparation of this review was not supported by any external funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Arnold Lee and Matt Shirley are salaried employees of Adis International Ltd\/Springer Nature, and declare no relevant conflicts of interest. All authors contributed to the review and are responsible for the article content.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authorship and conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval, Consent to participate, Consent to publish, Availability of data and material, Code availability"}}]}}